| JTH2400027 | 布地奈德福莫特罗吸入粉雾剂安慰剂 | budesonide;formoterol fumarate | Inhalation | Chemical Drugs | Disposable Import Drug Application | 2024-02-29 | | | | | view |
| CXHL2300939 | 布地奈德福莫特罗吸入粉雾剂（胶囊型） | budesonide;formoterol fumarate | Inhalation | Chemical Drugs(2.2) | New Drug Application | 2023-09-01 | | Zhuhai Resproly Pharmaceutical Technology Co Ltd | | | view |
| JYHL2100001 | 布地奈德福莫特罗吸入粉雾剂 | budesonide;formoterol fumarate | Inhalation | Chemical Drugs(5.2) | Import Drug Application | 2021-02-11 | | Orion Corporation | In Review | 2021-02-11 | view |
| JYHL2100003 | 布地奈德福莫特罗吸入粉雾剂 | budesonide;formoterol fumarate | Inhalation | Chemical Drugs(5.2) | Import Drug Application | 2021-02-11 | | Orion Corporation | In Review | 2021-02-11 | view |
| JYHL2100002 | 布地奈德福莫特罗吸入粉雾剂 | budesonide;formoterol fumarate | Inhalation | Chemical Drugs(5.2) | Import Drug Application | 2021-02-11 | | Orion Corporation | In Review | 2021-02-11 | view |
| JYHZ1800448 | 布地奈德福莫特罗粉吸入剂 | budesonide;formoterol fumarate | Inhalation | Chemical Drugs | License Renew | 2018-12-26 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2019-05-20 | view |
| JYHZ1800447 | 布地奈德福莫特罗粉吸入剂 | budesonide;formoterol fumarate | Inhalation | Chemical Drugs | License Renew | 2018-12-26 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2019-05-20 | view |
| JYHZ1800449 | 布地奈德福莫特罗粉吸入剂 | budesonide;formoterol fumarate | Inhalation | Chemical Drugs | License Renew | 2018-12-26 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2019-05-20 | view |
| JYHB1800533 | 布地奈德福莫特罗粉吸入剂 | budesonide;formoterol fumarate | Inhalation | Chemical Drugs | Supplementary Application | 2018-05-10 | AstraZeneca AB | AstraZeneca AB | Certificate Issued | 2018-07-10 | view |
| JYHB1800532 | 布地奈德福莫特罗粉吸入剂 | budesonide;formoterol fumarate | Inhalation | Chemical Drugs | Supplementary Application | 2018-05-10 | AstraZeneca AB | AstraZeneca AB | Certificate Issued | 2018-07-10 | view |
| JYHB1800531 | 布地奈德福莫特罗粉吸入剂 | budesonide;formoterol fumarate | Inhalation | Chemical Drugs | Supplementary Application | 2018-05-10 | AstraZeneca AB | AstraZeneca AB | Certificate Issued | 2018-07-10 | view |
| JYHB1800534 | 布地奈德福莫特罗粉吸入剂 | budesonide;formoterol fumarate | Inhalation | Chemical Drugs | Supplementary Application | 2018-05-10 | AstraZeneca AB | AstraZeneca AB | Certificate Issued | 2018-07-10 | view |
| JYHB1701500 | 布地奈德福莫特罗粉吸入剂 | budesonide;formoterol fumarate | Inhalation | Chemical Drugs | Supplementary Application | 2017-12-13 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2018-03-20 | view |
| JYHB1701499 | 布地奈德福莫特罗粉吸入剂 | budesonide;formoterol fumarate | Inhalation | Chemical Drugs | Supplementary Application | 2017-12-13 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2018-03-20 | view |
| JYHB1701498 | 布地奈德福莫特罗粉吸入剂 | budesonide;formoterol fumarate | Inhalation | Chemical Drugs | Supplementary Application | 2017-12-13 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2018-03-20 | view |
| JYHB1701490 | 布地奈德福莫特罗粉吸入剂 | budesonide;formoterol fumarate | Inhalation | Chemical Drugs | Supplementary Application | 2017-11-29 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Filed | 2018-02-02 | view |
| JYHB1701492 | 布地奈德福莫特罗粉吸入剂 | budesonide;formoterol fumarate | Inhalation | Chemical Drugs | Supplementary Application | 2017-11-29 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Filed | 2018-02-02 | view |
| JYHB1701491 | 布地奈德福莫特罗粉吸入剂 | budesonide;formoterol fumarate | Inhalation | Chemical Drugs | Supplementary Application | 2017-11-29 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Filed | 2018-02-02 | view |
| JYHB1701272 | 布地奈德福莫特罗粉吸入剂 | budesonide;formoterol fumarate | Inhalation | Chemical Drugs | Supplementary Application | 2017-09-30 | AstraZeneca AB | AstraZeneca AB | Filed | 2017-10-13 | view |
| JYHB1701271 | 布地奈德福莫特罗粉吸入剂 | budesonide;formoterol fumarate | Inhalation | Chemical Drugs | Supplementary Application | 2017-09-30 | AstraZeneca AB | AstraZeneca AB | Filed | 2017-10-13 | view |
